Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 8 - The Real Truth

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target specific tumor mutations. The vaccine, combined with Keytruda, significantly reduced cancer recurrence in trials. Doctors are hopeful this approach will expand to treat many other cancer types. Further trials are…

The Economic Times

Trump’s FDA Pick Heidi Overton Faces Republican Resistance as Bill Cassidy Calls Vaccine Order Role ‘Almost Disqualifying’

President Donald Trump’s choice of Dr. Heidi Overton to lead the Food and Drug Administration faced Republican resistance Wednesday as Senate Health Committee Chair Bill Cassidy (R-La.) said her role in the administration’s vaccine order was "almost disqualifying."

Benzinga

Two Grant County Cases Push the Southwestern Wisconsin Measles Outbreak to Thirty Six Confirmed and Three Probable

Wisconsin health officials confirmed measles in Grant County, expanding a southwestern outbreak the state says is now spreading locally.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

A Pooled 24 Country Analysis Ties Rotavirus Vaccination to Fewer Deaths Among Children Hospitalized with Diarrhea

A Lancet analysis pooling case-control studies across 24 countries links rotavirus vaccination to lower mortality from rotavirus gastroenteritis.

Medical Daily

Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

Moderna Inc.’s (NASDAQ:MRNA) latest cancer-vaccine breakthrough could be doing more than sending its stock sharply higher. It may be giving investors a reason to revisit an mRNA investment thesis that has largely been defined by COVID-19. ETFs tied to precision medicine names are also getting a boost.

Benzinga

Trump Adds to Wealth With Moderna Stock Gains: Here’s How Much President Made

Moderna Inc. (NASDAQ:MRNA) stock soared Wednesday after the company and Merck reported positive Phase 3 results for a personalized mRNA cancer vaccine, marking a major milestone for the emerging technology. Shares jumped more than 100%, reaching levels not seen since May 2024.

Benzinga

Who Is Dr. Heidi Overton? Trump's FDA Nominee Once Stood By Him Over False Autism-Vaccine Claim

President Trump nominates Dr. Heidi Overton to lead the FDA, sparking controversy over her stance on vaccination protocols and facing a divided Senate for confirmation amidst ongoing public health challenges.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

The vaccine could be available as soon as 2027.

Reason

Trump nominates staunch abortion critic Dr. Heidi Overton to lead FDA

Democratic lawmakers quickly and forcefully denounced Trump’s pick online

The Independent UK

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring

The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

Fortune

This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results

Moderna stock rips higher on a major cancer breakthrough. The announcement led William Blair to upgrade MRNA shares to "Outperform."

Barchart

Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration

President Donald Trump has picked Dr. Heidi Overton to lead the Food and Drug Administration

The Independent UK

Trump nominates abortion opponent Heidi Overton to be head of FDA

Overton has said that Congress should strictly regulate abortion drug mifepristone ‘to protect women and children’

The Guardian - US

Moderna Shares Double Overnight Because a Made-to-Order mRNA Vaccine Actually Beats Skin Cancer

Moderna's personalised mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence in a Phase 3 trial, doubling the company's stock value and marking a milestone in cancer treatment.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

The late-stage clinical trial was described as a "landmark moment."

The Economic Times

Moderna shares soar 159% in a day after cancer vaccine succeeds in late-stage trial

Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This marks the first successful late-stage trial for an mRNA cancer vaccine. The findings offer hope for future growth beyond COVID-19 vaccines. Discussions with regulators are…

Medical Daily

Most American Adults Show No Measurable Immunity to Hepatitis A or B Despite Decades of Vaccines

A JAMA Internal Medicine analysis found 39.5% of US adults had serologic immunity to hepatitis A and just 27.1% had it for hepatitis B.

The Conversation

The CDC has a new director – now comes the hard part

The new director of the Centers for Disease Control and Prevention, Erica Schwartz, confirmed by the U.S. Senate on Aug. 5, 2026, is only the second CDC director to face Senate confirmation. Congress adopted the process for the agency after the COVID-19 pandemic to bring more scrutiny to one of…

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Trump Chosen White House Adviser Dr. Heidi Overton to Lead FDA Amid Outbreaks

Trump has chosen White House adviser Dr. Heidi Overton to lead the FDA, an agency down more than 3,000 staff amid open food outbreaks.

Medical Daily

Congo Ebola Deaths Top 2,300 as WHO Warns Crisis Persists

WHO's emergency committee reconvened on the Congo Ebola epidemic as deaths passed 2,300, with officials calling the outbreak far from under control.

The Independent UK

Should you book your flu vaccine now? Expert advice as NHS opens appointments

NHS flu jabs start from 1 September for children and pregnant women

Benzinga

Trump Picks White House Health Adviser Heidi Overton to Lead FDA After Marty Makary’s Exit

President Donald Trump has selected White House health-policy adviser Heidi Overton as his nominee to lead the Food and Drug Administration, putting a physician closely involved in the administration’s health agenda in line to take over an agency rebuilding after former Commissioner Marty Makary‘s resignation and more than 3,000 staff…

Medical Daily

Rosie's Cancer Came Back After Her AI-Designed Vaccine, and Her Owner Just Raised $4 Million

Rosie's AI-designed mRNA vaccine went viral in March. Her cancer later returned, and her owner's startup launched with Founders Fund backing.

The Canberra Times

Surge in demand drives shortage of pneumonia, shingles medicines

Here's what you need to know.

Medical Daily

Colorado Quarantines More Horse Properties as a Blistering Livestock Virus That Can Infect People Spreads Again

Vesicular stomatitis has reached four Colorado counties this year. The virus rarely infects people, but handlers of sick animals can catch it.

1 … 7 8 9 10

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

328 stories

the Centers for Disease Control and Prevention

245 stories

MRNA

233 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.